Med City can galvanise science and business in the UK

15 April 2014

Stephen Caddick

Med City was launched to great fanfare last week by the Mayor of London, Boris Johnson. Bringing together the powerhouses of academic and clinical research at UCL, Imperial, Kings, Oxford and Cambridge, it’s a hugely welcome development. Critics have questioned whether the initiative is really needed or runs the risk of adding additional layers of unnecessary bureaucracy, but Med City has an important role to play in galvanising the talents of the UK’s life science researcher, writes Professor Stephen Caddick (UCL Vice-Provost, Enterprise) in The Conversation.